Intermolecular (IMI) Reports In-Line Q4 EPS, Offers Q1 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Intermolecular Reports Fourth Quarter and Full Year 2018 Financial Results
February 12, 2019 4:05 PM ESTSAN JOSE, Calif., Feb. 12, 2019 /PRNewswire/ -- Intermolecular, Inc. (Nasdaq: IMI), the trusted partner for advanced materials innovation, today reported results for the fourth quarter and full year ended December 31, 2018.
Q4 2018 Financial and Operational Highlights
Revenue of $6.3 million, which exceeded the company's guidance. Program revenue totaled $6.0 million or 95% of total revenue. Gross profit totaled $4.6 million or 73% of total revenue. Adjusted EBITDA loss totaled $(1.5) million, which exceeded the company's guidance. Net loss totaled $(2.6) million. Secured two program contracts during the period,... More